Signaling Pathways and Emerging Therapies in Multiple Myeloma.
about
The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma.Silencing of augmenter of liver regeneration inhibited cell proliferation and triggered apoptosis in U266 human multiple myeloma cells.Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells.PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promise.
P2860
Signaling Pathways and Emerging Therapies in Multiple Myeloma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Signaling Pathways and Emerging Therapies in Multiple Myeloma.
@en
type
label
Signaling Pathways and Emerging Therapies in Multiple Myeloma.
@en
prefLabel
Signaling Pathways and Emerging Therapies in Multiple Myeloma.
@en
P2860
P1476
Signaling Pathways and Emerging Therapies in Multiple Myeloma.
@en
P2093
Anita D'Souza
Vijay Ramakrishnan
P2860
P2888
P304
P356
10.1007/S11899-016-0315-4
P577
2016-02-27T00:00:00Z
P6179
1049343933